By: ICN Bureau
Last updated : July 27, 2025 4:48 pm
Company remain focus on increasing its product registrations in FY26, with planned Capex of around Rs. 400-450 crores
Sharda Cropchem Limited (SCL), one of the leading players in the generic crop protection chemicals industry, Q1 FY26 revenue has shown growth of 25% to reach Rs. 984.8 crore whereas gross profit has increased by 53% to reach Rs. 349.2 crore.
Agrochemical Segment contributes 86% whereas Non-Agrochemical Segment contributes 14%. Overall Volumes have increased by 13.2% Y-o-Y in Q1 FY26. Agrochemical volumes grew by 11.4% & Non-Agrochemical volumes grew by 59%. Capex in Q1 FY26 stands at Rs. 114 crores. Product Registrations stand at 2,981 with 1,021 applications pending at various stages as on 30th June 2025. The company remains debt free with cash, bank and liquid investments of Rs. 791 crores.
Commenting on the results, Ramprakash Bubna, Chairman and MD said, “In Q1 FY26, we recorded strong volume growth of ~13%, with revenues rising ~25% YoY to Rs. 985 crores. This performance was driven by a global demand revival and improved pricing. Europe remains a key contributor in both volume and value terms. With input costs stabilizing, our Gross Margins have expanded by 630 basis points to 35.5% and we expect GP Margins to remain in a similar range going ahead. EBITDA has grown by 67% to Rs. 142 crores with EBITDA Margins at 14.4%. We remain focused on increasing our product registrations in FY26, with planned Capex of around Rs. 400-450 crores. Our strong pipeline of registrations reflects both our resilience and unwavering commitment to growth, laying a strong foundation for sustained future progress. For FY26, we aim to grow our topline by ~15% while maintaining healthy EBITDA Margins in the range of 15–18%.”